The trademark application IMDYLLTRA was filed by Amgen Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 19, 2023, and it was registered by office on January 26, 2024 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on November 5, 2023.